Cargando…
Conivaptan and its role in the treatment of hyponatremia
Hyponatremia is the most common electrolyte abnormality in hospitalized patients and is associated with increased morbidity and mortality. The recognition of the central role that arginin vasopressin plays in the pathogenesis of hyponatremia and the discovery that its actions are mediated by stimula...
Autores principales: | Ghali, Jalal K, Farah, Jareer O, Daifallah, Suleiman, Zabalawi, Hassan A, Zmily, Hammam D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802125/ https://www.ncbi.nlm.nih.gov/pubmed/20054444 |
Ejemplares similares
-
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Conivaptan: a step forward in the treatment of hyponatremia?
por: Hline, Su Su, et al.
Publicado: (2008) -
Conivaptan: Evidence supporting its therapeutic use in hyponatremia
por: Li-Ng, Melissa, et al.
Publicado: (2010) -
Dose comparison of conivaptan (Vaprisol(®)) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics
por: Palmer, Biff F, et al.
Publicado: (2016) -
Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan
por: Rajan, Sunil, et al.
Publicado: (2018)